Page 483 - Critical Care Nursing Demystified
P. 483

468        INDEX



                     end-stage renal disease (ESRD), 356, 371, 388t  fluid volume replacement (FVR) (Cont.):
                     EOMs. See extraocular movements               colloids for, 274–275
                     eosinophils, 403                              complications of, 274
                     epicardial pacemakers, 86, 194t, 197–198      crystalloids in, 273, 274t
                     epidural hematoma, 254–255                    sites of, 272, 273t
                     epidural sensor, 234                          solutions for, 272–273
                     epinephrine, 117t, 415t                     fl umazenil, 60
                     EPO, 370t                                   focused assessment with sonography for
                     epoetin alfa, 415t                             trauma (FAST), 266, 304
                     Epogen, 415t                                Folacin, 369t
                     error disclosure and reporting, 11          folic acid, 369t
                     ERV. See expiratory reserve volume          Folvite, 369t
                     erythrocyte, 402. See also red blood cells  forced expiratory volume (FEV ), 39t
                                                                                        1
                     erythrocyte sedimentation rate (ESR), 107, 410t  Fosrenol, 368t
                     erythropoietin, 402–403                     4A’s model, 13t
                     escaped beats, 164, 178                     IV vitamin D, 367t
                     eschar, 266, 273t                           FPD. See fi brin degradation products
                     esomeprazole, 370t                          fraction of inspired oxygen (FiO ), 20, 35, 51t
                                                                                         2
                     ESR. See erythrocyte sedimentation rate     fractional excretion of sodium (FENa), 356, 363
                     ESRD. See end-stage renal disease           fractured ribs, 283–285, 284f
                     ETT. See endotracheal tube                  furosemide, 106, 113t, 240t, 365t
                     euthyroid, 312, 331
                     Exenatide, 340                              G
                     expiratory reserve volume (ERV), 39t
                     external respiration, 23–24                 gallops, 86, 93
                     extracellular fluid (ECF), 312, 314t         Gamma Knife, 251                               Downloaded by [ Faculty of Nursing, Chiangmai University 5.62.158.117] at [07/18/16]. Copyright © McGraw-Hill Global Education Holdings, LLC. Not to be redistributed or modified in any way without permission.

                     extraocular movements (EOMs), 225           gas exchange, 23–24
                                                                 GBS. See Guillain-Barré Syndrome
                     F                                           GCS. See Glasgow Coma Scale
                                                                 gestational diabetes, 341
                     famotidine, 369t                            GFR. See glomerular fi ltration rate
                     fasciotomy, 266                             GH. See growth hormone
                     FAST. See focused assessment with sonography  giantism, 317–318
                         for trauma                              Glasgow Coma Scale (GCS), 210, 217
                     fasting blood sugar (FBS), 335                for neurological needs assessment, 219–220
                     FENa. See fractional excretion of sodium    glomerular fi ltration rate (GFR), 356, 363, 388
                     Fentanyl, 60                                glossitis, 402
                     Feosol, 370t                                glucagon, 335
                     ferrous sulfate, 370t                       glucose, 334–335, 368t
                     FEV . See forced expiratory volume            impaired tolerance for, 342
                         1
                     fi brin, 403                                   insulin, controlling levels of, 340
                     fi brin degradation products (FDP), 410t     α-Glucosidase inhibitors, 338t
                     fi brinogen levels, 410t                     glycogen, 335
                     fi ne-needle biopsy, 328                     glycosylated hemoglobin, 335
                     fi ngerstick glucose test, 335               Golden Hour, 266, 268
                     fi nger-to-nose test, 220                    granulocytes, 402–403
                     FiO . See fraction of inspired oxygen       Graves’ disease, 312, 326
                        2
                     fi rst-degree AV block, 186                  growth hormone (GH)

                     flail chest, 283–285, 284f                     causes of elevated, 315–316
                     fluid rebound, 356, 367                        excessive secretion of, 314–315

                     fluid volume replacement (FVR)                 hypopituitarism caused by lack of, 318

                       blood transfusion aiding, 275–276         Guillain-Barré Syndrome (GBS)
                       calculation for, 301                        causes of, 243
   478   479   480   481   482   483   484   485   486   487   488